286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
Main Author: | Leyuan Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens
by: Si-Wei Zhang, et al.
Published: (2023-11-01) -
Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk
by: Hongquan Qin, et al.
Published: (2023-10-01) -
256 Dual-targeted CAR T cells boost antitumor immunity against solid tumors
by: Ziming Wang, et al.
Published: (2023-11-01) -
Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens.
by: Golgher, D, et al.
Published: (2002) -
Glioma–Immune Cell Crosstalk in Tumor Progression
by: Mahmoud Elguindy, et al.
Published: (2024-01-01)